Balentine LLC’s iShares US Medical Devices ETF IHI Stock Holding History

Balentine LLC’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$32.3K	Hold	654	–	–	﹤0.01%	216
2026 Q1	$34.9K	Hold	654	–	–	﹤0.01%	200
2025 Q4	$40.6K	Hold	654	–	–	﹤0.01%	201
2025 Q3	$39.3K	Buy	+654	New	+$40K	﹤0.01%	206
2021 Q2	–	Sell	-282	Closed	-$16K	–	229
2021 Q1	$16K	Sell	282 -2,928	-91%	-$162K	﹤0.01%	186
2020 Q4	$175K	Buy	+3,210	New	+$168K	0.01%	132

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Balentine LLC's IHI Position: Q2 2026 in Review

Balentine LLC held its iShares US Medical Devices ETF (IHI) position steady in Q2 2026 at 654 shares worth $32.3K. The position accounts for ﹤0.01% of the portfolio, ranked #216.

Balentine LLC first reported a position in IHI in Q4 2020 and has held it in 6 quarters since. The position peaked at $175K in Q4 2020. 505 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Balentine LLC held 654 shares of iShares US Medical Devices ETF worth $32.3K as of Q2 2026.
Balentine LLC left its iShares US Medical Devices ETF share count unchanged in Q2 2026.
iShares US Medical Devices ETF made up ﹤0.01% of Balentine LLC's portfolio in Q2 2026, its #216 holding.
Balentine LLC first reported a position in iShares US Medical Devices ETF in Q4 2020 and has held it in 6 quarters since.
Balentine LLC's iShares US Medical Devices ETF position peaked at $175K in Q4 2020.
505 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Balentine LLC's 13F filing for Q2 2026, filed 6 Aug 2026.